HCP Live
Contagion LiveCGT LiveNeurology LiveHCP LiveOncology LiveContemporary PediatricsContemporary OBGYNEndocrinology NetworkPractical CardiologyRheumatology Netowrk
CGTLive’s Weekly Rewind – November 25, 2022

Review top news and interview highlights from the week ending November 25, 2022.

NRTX-1001 Reduces Mesial Temporal Lobe Epilepsy Seizures in 2 Patients

The first participant has been followed-up for 3 months so far after treatment while the second is only 1 week post-treatment.

Around the Helix: Cell and Gene Therapy Company Updates – November 23, 2022

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Amod Sarnaik, MD, on New Frontiers in Cell Therapy for Advanced Melanoma

Sarnaik discussed several potential areas of innovation on the horizon.

Hemgenix First Gene Therapy Approved for Hemophilia B

A marketing authorization application for etranacogene dezaparvovec is currently under review by the EMA.